NCT05899517 is a NA clinical trial of oral lollipop with oxytocin (24IU) in Healthy, sponsored by University of Electronic Science and Technology of China.

Who is sponsoring NCT05899517?

NCT05899517 is sponsored by University of Electronic Science and Technology of China.

What drugs are being tested in NCT05899517?

Interventions in NCT05899517: oral lollipop with oxytocin (24IU), oral lollipop with placebo.

Is NCT05899517 still recruiting?

NCT05899517 is currently status unknown. Last updated 12 June 2023.

Last reviewed 2023-06-12 · How we verify

NCT05899517

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Oxytocin Effects on Self Versus Other Touch

Status unknown NA Last updated 12 June 2023

What this trial tests

NA trial testing oral lollipop with oxytocin (24IU) in Healthy in 40 participants. Status unknown.

Timeline

22 June 2022

Primary endpoint
30 July 2023

1 December 2023

Quick facts

Lead sponsor	University of Electronic Science and Technology of China
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	triple
Primary purpose	basic science
Enrollment	40
Start date	22 June 2022
Primary completion	30 July 2023
Estimated completion	1 December 2023
Sites	1 location across China

Drugs / interventions tested

oral lollipop with oxytocin (24IU) — full drug profile →
oral lollipop with placebo — full drug profile →

Conditions studied

Healthy — all drugs for Healthy →

Sponsor

University of Electronic Science and Technology of China

Who can join

Adults 18 to 30, male only, with Healthy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The main aim of the study is to investigate the modulatory effects of oxytocin (24IU) administered orally using medicated lollipops on the behavioral and neural responses to touching yourself compared with being touched by others.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of oral lollipop with oxytocin (24IU)

Trials testing the same drug.

NCT05444738 — Effects of Oxytocin Administered Orally Using a Medicated Lollipop on Peripheral Concentrations and Attention · NA · unknown

Other recruiting trials for Healthy

Currently open trials in the same condition.

NCT06707207 — Predicting Future Errors During Skill Performance · recruiting
NCT07169630 — PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI) · Phase 1 · recruiting
NCT07499414 — The Effects of the Bile Acid Supplement, 7-keto Lithocholic Acid, on Human Gut Microbiota and Risk Factors for Disease. · NA · recruiting
NCT07496697 — Effects of Electroacupuncture at NP82 and SP15 on Bowel Motility in Healthy Subjects · NA · recruiting
NCT06431932 — Pilot Trial of Fisetin in Healthy Volunteers and Older Patients With Multimorbidity · Phase 1, PHASE2 · recruiting

Other University of Electronic Science and Technology of China trials

Trials by the same sponsor.

NCT07416370 — Neurofeedback Training of Anterior Insula Activity Based on Unidimensional vs. Multidimensional Interoceptive Regulation · NA · enrolling by invitation
NCT07389486 — Continuous vs. Intermittent Rt-fMRI Neurofeedback Training of the Anterior Insula · NA · recruiting
NCT07425938 — Oxytocin's Effects on Emotional Processing and Its Acting Routes · NA · recruiting
NCT07364084 — Real-time Neurofeedback Training of the Medial Prefrontal Cortex Based on Imagined Social Support · NA · recruiting
NCT07367672 — The Power of Belief: Expectation-driven and Placebo Modulation of Empathic Pain · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05899517 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Electronic Science and Technology of China
Last refreshed: 12 June 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05899517.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing